The oncogenic activation of the RET gene is recognised as an early pathogenic event in cancers, and this occurrence subsequently induces the downstream signalling events involving the MEK/ERK-, PI3K/AKT-, and phospholipase Cγ- (PLCγ-) dependent pathways [9]. Here, RET is linked to cancer.